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Abstract
In this study, concentrations of free amino acids (FAA) and amino group containing compounds (AGCC) following graded diffuse traumatic
brain injury (mild TBI, mTBI; severe TBI, sTBI) were evaluated. After 6, 12, 24, 48 and 120 hr aspartate (Asp), glutamate (Glu), asparagine
(Asn), serine (Ser), glutamine (Gln), histidine (His), glycine (Gly), threonine (Thr), citrulline (Cit), arginine (Arg), alanine (Ala), taurine (Tau), c-
aminobutyrate (GABA), tyrosine (Tyr), S-adenosylhomocysteine (SAH), L-cystathionine (L-Cystat), valine (Val), methionine (Met), tryptophane
(Trp), phenylalanine (Phe), isoleucine (Ile), leucine (Leu), ornithine (Orn), lysine (Lys), plus N-acetylaspartate (NAA) were determined in whole
brain extracts (n = 6 rats at each time for both TBI levels). Sham-operated animals (n = 6) were used as controls. Results demonstrated that
mTBI caused modest, transient changes in NAA, Asp, GABA, Gly, Arg. Following sTBI, animals showed profound, long-lasting modifications of
Glu, Gln, NAA, Asp, GABA, Ser, Gly, Ala, Arg, Citr, Tau, Met, SAH, L-Cystat, Tyr and Phe. Increase in Glu and Gln, depletion of NAA and Asp
increase, suggested a link between NAA hydrolysis and excitotoxicity after sTBI. Additionally, sTBI rats showed net imbalances of the Glu-Gln/
GABA cycle between neurons and astrocytes, and of the methyl-cycle (demonstrated by decrease in Met, and increase in SAH and L-Cystat),
throughout the post-injury period. Besides evidencing new potential targets for novel pharmacological treatments, these results suggest that
the force acting on the brain tissue at the time of the impact is the main determinant of the reactions ignited and involving amino acid metabo-
lism.
Keywords: cerebral free amino acids excitotoxicity high performance liquid chromatographymethyl-cycle
N-acetylaspartatemild traumatic brain injury severe traumatic brain injury
Introduction
Under physiological conditions, free amino acids (FAA) and amino
group containing compounds (AGCC), exert fundamental biochemical
roles in numerous brain functions. They can roughly be divided into
different categories: (1) those directly involved in neurotransmission,
such as glutamate (Glu) and c-aminobutyrric acid (GABA) [1]; (2)
those participating to neurotransmission, such as D-serine (D-Ser)
and glycine (Gly) [2]; (3) those indirectly controlling neurotransmis-
sion, such as glutamine (Gln), aspartate (Asp), triptophane (Trp),
phenylalanine (Phe) and tyrosine (Tyr) [3–5]; (4) those indirectly
involved in cellular energy metabolism, such as leucine (Leu), isoleu-
cine (Ile) and valine (Val) [6]; (5) those involved in specific metabolic
pathways, such as methione (Met), cystathionine (L-Cystat) and
S-adenosylhomocysteine (SAH) [7].
Besides, several of them have multiple functions: for instance, Glu
and Gly are both substrates necessary for the biosynthesis of reduced
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glutathione (GSH), the main cerebral low molecular weight antioxi-
dant [8]; Glu is also needed for the synthesis of an additional neuro-
transmitter, namely N-acetylaspartylglutamate (NAAG) [9]; Asp is one
of the substrate used for the synthesis of N-acetylaspartate (NAA),
the most abundant, neuron specific, N-acetylated amino acid found in
the brain [10]; both Asp and Glu participate in the regulation of brain
energy metabolism as anaplerotic and cataplerotic compounds of the
tricarboxylic acid (TCA) cycle [11].
According to data from animal studies, it appears that the physi-
ological pool of FAA within whole brain tissue is not subjected to
significant fluctuations [12, 13], whereas the levels of these com-
pounds are affected, to various degrees, in some cerebral patholo-
gies. Experimental brain ischaemia and reperfusion [14], animal
model of amyotrophic lateral sclerosis [15] and experimental sei-
zures [16] have been shown to influence several of the aforemen-
tioned substances.
Traumatic brain injury (TBI) is the leading cause of death and
disability in young adults (below 45 years of age) in Western
countries [17]. Excluding prevention, currently there are no thera-
pies available to reduce TBI-associated damage, partly owing to
our incomplete understanding of the cellular and molecular mecha-
nisms of injury [18], so that it is not incorrect to state that TBI
patients are still waiting for a satisfactory pharmacological
approach. As thoroughly scrutinized and demonstrated, given the
visible, morphological damage, a further, profound, hidden and
somehow ‘invisible’ biochemical harm also exists, initiated by the
inertial forces acting on the brain tissue at the time of impact (ro-
tational, translational). These forces trigger a cascade of molecular
events altering a plethora of cellular functions including ionic
homeostasis [19], mitochondrial functions [20], energy metabolism
[21], neurotransmission [22], signal transduction [23], protein
folding [24], gene expression [25], apoptosis [26]. Various experi-
mental studies have ultimately demonstrated that these and other
changes are strictly related to severity of injury [27], on turn
related to the amount of the mechanical energy transferred at the
time of impact, with mild TBI (mTBI) mostly causing sponta-
neously resolving changes [28], and with severe TBI (sTBI) mainly
provoking permanent alterations of pivotal cerebral cell functions
[29, 30].
Notwithstanding the impressive, constantly increasing, number of
studies on TBI, up to date there are no comprehensive data on
changes potentially occurring to all FAA and ACCG following TBI.
Most of the studies have so far focused on amino acids mainly
involved in neurotransmission [31–33]. None has been carried out in
TBI of different severity. Hence, very little is known in relation to
about 10–15 compounds involved in various cell functions and how
such a pathophysiology highlight might contribute to potential new
targets for pharmacological interventions.
In this study, by using the same brain samples deriving from
cohorts of control rodents and of rats experiencing mTBI or sTBI,
previously used to assess various biochemical and molecular
effects caused by graded TBI [34–36], we have determined the
concentrations of FAA and ACCG at different times following the
two levels (mild and severe) of experimental diffuse closed head
injury.
Materials and methods
Chemicals
High performance liquid chromatography (HPLC)-grade tetrabuty-
lammonium hydroxide, used as the pairing reagent in the separa-
tion of N-acetylaspartate, (NAA), ortophtalaldehyde (OPA) and 3-
mercaptopropionic acid (MPA), used as the reagents to obtain fluo-
rescent-derivatized amino compounds, as well as ultrapure NAA,
standard and non-standard amino acids and amino compounds,
were supplied from Sigma-Aldrich (St. Louis, MO, USA). HPLC-
grade acetonitrile, methanol and tetrahydrofurane were purchased
from J.T Baker (Mallinckrodt Baker, Deventer, the Netherlands). All
other chemicals were of the highest purity available from commer-
cial sources.
Experimental protocol
The experimental protocol was approved by the Ethical Committee of
the Catholic University of Rome, according to international standards
and guidelines for animal care. As previously described, Male Wistar
rats of 300–350 g were randomly divided into three groups: (1) sham-
operated as control; (2) mild diffuse TBI (mTBI group); (3) severe dif-
fuse TBI (sTBI group) [34–36]. As for the anaesthetic mixture, animals
received 35 mg/kg b.w. ketamine and 0.25 mg/kg b.w. midazolam by
i.p. injection. Since we were interested in a type of trauma producing a
diffuse axonal injury, graded TBI (mTBI or sTBI) was induced according
to the weight drop impact acceleration model characterized by causing
diffuse axonal damage [37]. After anaesthesia, a metal disk was fixed
onto the central portion of the skull, between the coronal and lambdoid
sutures, to prevent skull fracture and to homogenously distribute the
force acting at the time of impact. Mild or severe TBI were induced by
dropping a cumulative weight of 450 g from 1 or 2 m height and know-
ing to cause, respectively, a mTBI or a sTBI either histopathologically or
biochemically [34–38]. At 6, 12, 24, 48 and 120 hrs from injury, rats
were again anaesthetized (n = 6 for each time-point in both groups of
injured animals) and then immediately killed. Sham-operated animals
were killed 120 hr after the initial anaesthesia (n = 6) and used as
controls.
Tissue preparation for the determination of
amino acids, amino-compounds and NAA
As described elsewhere [38], an in vivo craniectomy was performed
in all animals during anaesthesia, the brain was exposed, sharply
cut along the sagittal fissure and the two hemispheres were
freeze-clamped in liquid nitrogen to minimize metabolite loss
[34–36].
The tissue preparation was performed on one hemisphere, using
the organic solvent deproteinizing procedure described elsewhere
[39]. A total of three right + three left hemispheres for each time-
point in both groups of rats (mTBI and sTBI), as well as for the
control group, were processed as described above to give clear
aqueous 10% protein-free tissue extracts suitable for the HPLC anal-
ysis of free amino acids, amino-compounds and NAA.
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HPLC separation of amino acids,
amino-compounds and NAA
The HPLC apparatus (ThermoFisher Italia, Rodano, Milan, Italy) con-
sisted of a P4000 quaternary pump system, an AS3000 autosampler
and a highly sensitive UV6000LP photodiode array detector equipped
with a 5 cm light path flow cell and set up between 200 and 400 nm
wavelength. Data acquisition and analysis were performed by a PC
using the ChromQuest software package provided by the HPLC manu-
facturer.
The simultaneous determination of 24 primary FAA and ACCG,
including Asp, Glu, asparagine (Asn), serine (Ser), Gln, histidine (His),
Gly, threonine (Thr), citrulline (Cit), arginine (Arg), alanine (Ala), taurine
(Tau), GABA, Tyr, SAH, L-Cystat, Val, Met, Trp, Phe, Ile, Leu, ornithine
(Orn) and lysine (Lys), plus the internal standard norvaline (Norval),
was performed using the pre-column derivatization of the sample with a
mixture of OPA and MPA, as described elsewhere [40]. Briefly, the
derivatization mixture composed by 25 mmol/l OPA, 1% MPA,
237.5 mmol/l sodium borate, pH 9.8 was prepared daily and placed in
the autosampler. The automated precolumn derivatization of the sam-
ples (15 ll) with OPA-MPA was carried out at 24°C and 25 ll of the
derivatized mixture were loaded onto the HPLC column (Hypersil C-18;
250 9 4.6 mm, 5 lm particle size, thermostated at 21°C) for the sub-
sequent chromatographic separation. In the case of Glu, deproteinized
brain extracts were diluted 20 times with HPLC-grade H2O prior to
the derivatization procedure and subsequent injection. Separation of
OPA-AA and OPA-ACCG was carried out at a flow rate of 1.2 ml/min
using two mobile phases (mobile phase A = 24 mmol/l
CH3COONa + 24 mmol/l Na2HPO4 + 1% tetrahydrofurane + 0.1% triflu-
oroacetic acid, pH 6.5; mobile phase B = 40% CH3OH + 30%
CH3CN + 30% H2O), using an appropriate step gradient [41]. Assign-
ment and calculation of the OPA-AA and OPA-ACCG in chromatographic
runs of whole brain extracts were carried out at 338 nm wavelengths
by comparing retention times and areas of peaks with those of peaks of
chromatographic runs of freshly prepared ultra-pure standard mixtures
with known concentrations.
The determination of NAA was carried out isocratically on 10 ll of
deproteinized whole brain extracts, as described elsewhere [42]. Assign-
ment and calculation of NAA was carried out at 206 nm wavelengths by
comparing retention time, absorption spectrum and area of the NAA
peak in sample runs with those of chromatographic runs of freshly pre-
pared ultra-pure NAA with known concentration.
Statistical analysis
Normal data distribution was tested using the Kolmogorov-Smirnov test.
The within group comparison at each time was performed by the one-
way analysis of variance (ANOVA). Differences across groups were esti-
mated by the two-way ANOVA for repeated measures. Fisher’s protected
least square was used as the post hoc test. Only two-tailed P-values of
<0.05 were considered statistically significant.
Results
In Fig. 1, the changes in Glu, Gln, Glu + Gln and Glu/Gln ratio at dif-
ferent times post-graded TBI are illustrated. Concentration of whole
brain Glu after mTBI (Fig. 1A) show a slight but not significant
increase at 6, 24 and 48 hrs post impact (+12%, +2% and +7%,
respectively). Differently, in animal receiving sTBI, Glu values were
significantly higher than controls at 24 (+55%), 48 (+30%) and
120 hrs (+43%) after insult (P < 0.01 with respect to control values).
Concentration of Glu at these time-points was also significantly higher
than that recorded in mTBI rats (P < 0.01). The determination of Gln
(Fig. 1B) showed that mTBI did not affect the concentration of this
amino acid, whilst an increase at 24 and 48 hrs post-sTBI was
recorded (maximal increase = +30% at 48 hrs; P < 0.01 with
respect to both controls and mTBI rats). In consequence of the differ-
ential changes of Glu and Gln in the two types of trauma, the
Glu + Gln sum (Fig. 1C) was not affected by mTBI, whilst higher val-
ues were recorded at 24, 48 and 120 hrs after sTBI (+43%, +30%
and +29%, respectively; P < 0.01 compared to both controls and
mTBI rats). Also the Glu/Gln ratio (Fig. 1D) did not increase following
mTBI and underwent significant increase in sTBI rats at 6, 24 and
120 hrs post-injury (+26%, +39% and +48%, respectivley, P < 0.01
compared to control rats).
Because of the possible interdependence between NAA and Asp
variations, in Fig. 2 we compared the changes in NAA, Asp and
NAA + Asp in whole brain extracts of mTBI and sTBI rats at different
times post-injury. Variations of NAA (Fig. 2A) confirmed previous
observations [34–36] showing a transient decrease at 6 and 24 hrs
(19% and 23%, respectively; P < 0.01 compared to controls) and
a full restoration at 48 and 120 hrs after mTBI, and a steady profound
depletion at any time after sTBI (33%, 47%, 49% and 52% at
6, 24, 48 and 120 hrs, respectively; P < 0.001 compared to both con-
trols and mTBI rats). As illustrated in Fig. 2B, when considering the
change in brain Asp concentration (calculated in lmol/g wet weight),
an increase in 1.96 and 1.36 lmol/g wet weight was recorded at 6
and 24 hrs, respectively, after mTBI (P < 0.01 compared to con-
trols). Concentration of Asp in sTBI animals increased by 2.80, 2.07,
1.19 and 1.18 lmol/g wet weight at 6, 24, 48 and 120 hrs, respec-
tively (P < 0.01 compared to both controls and mTBI rats). According
to the data of Fig. 2C, the increase in Asp observed in mTBI rats
equalled (in concentration) the decrease in NAA, so that the sum of
these two interconnected compounds (NAA + Asp) did not change at
any time after a mild injury. The NAA + Asp sum in brain tissue of
sTBI animals was significantly lower than controls at 6 (11%;
P < 0.05), 48 (13%; P < 0.05) and 120 hrs post-injury (15%;
P < 0.05), indicating that the increase in Asp (in concentration) was
not equal to the decrease in NAA (in concentration), i.e. Asp produced
by NAA hydrolysis was converted into different compounds or was
cleared out of the cerebral tissue.
The influence of graded TBI on the main inhibitory neurotrans-
mitter amino acid (GABA) and one important amino compound
osmolite (Tau) are shown in Fig. 3. Animals receiving mTBI showed
a significant increase in GABA (Fig. 3A) at 6 and 24 hrs post-impact
(+30% and +38%; P < 0.01 respect to controls), with values not
significantly different from those of controls at 48 and 120 hrs after
insult. Severe injury caused an increase in GABA at any time post-
impact (+29%, +62%, +32% and +27%, respectively, at 6, 24, 48
and 120 hrs; P < 0.01 compared to controls and mTBI rats). In
mTBI injured rats, Tau increased only after 6 hrs from the insult
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(+35%, P < 0.01 respect to controls), whilst in sTBI injured rats an
increase in Tau was recorded at 24 and 48 hrs post-impact (+62%
and +38%, respectively, P < 0.01 compared to controls and mTBI
rats).
Ser, Thr, Gly and Ala were differently affected by the two
grades of TBI. As shown in Fig. 4A–D, mTBI provoked sporadic,
modest changes in these four amino acids, mainly within the first
24 hrs post-trauma. More evident and prolonged changes occurred
after sTBI, particularly for Ser, Gly and Ala all showing identical
time courses with maximal increases recorded at 48 hrs post-
insult.
Figure 5 illustrates changes in the concentrations of Arg and Citr,
and in the Arg/Citr ratio after mTBI or sTBI. Following a mild injury,
Arg initially decreased (40% at 6 hrs, P < 0.01 compared to con-
trols) and then increased resulting +62% and +48% higher than
controls (P < 0.01) at 48 and 120 hrs, respectively. Consistently
lower values of Arg than controls were found in brain homogenates
of sTBI animals (52%, 30%, 38%, 16% at 6, 24, 48, and
120 hrs, respectively; P < 0.01 compared to both controls and mTBI
rats). In mTBI rats, Citr underwent a 28% reduction at 6 hrs
(P < 0.01), followed by a recovery at 24 hrs, an increase by 44% at
48 hrs (P < 0.01) and a further normalization at 120 hrs post-
trauma. In sTBI animals, a 33% in Citr concentration was detected
at 6 hrs, followed hereinafter by normalization to pre-impact values.
As a consequence of the differential Arg and Citr changes occurring
in the two levels of injury, the Arg/Citr ratio, which is an indirect
indicator of nitric oxide (NO) production by endothelial, neuronal
and inducible nitric oxide synthases (eNOS, nNOS and iNOS), was
unchanged at 6, 24 and 48 hrs and was increased by 45% at
120 hrs (P < 0.01) after mTBI, whilst it was consistently lower at
any time post-sTBI (P < 0.01 compared to both control and mTBI
rats).
The variations of the remaining FAA and ACCG, determined at dif-
ferent times post-mTBI or -sTBI in deproteinized brain homogenates,
are summarized in Table 1. None of the 10 FAA (Asn, His, Tyr, Val,
Met Trp, Phe, Ile, Leu Lys) and of the two ACCG (SAH and L-Cystat)
were affected by a mild level of TBI. Conversely, the amino acids (Met
and L-Cystat and the amino group containing compound (SAH)
involved in the so called methyl-cycle, which regulates numerous
methylation reactions within a living cell, underwent remarkable
changes, with significant increase in SAH and concomitant decrease
in Met and increase in L-Cystat) particularly evident between 24 and
120 hrs post-injury (P < 0.01 compared to both control and mTBI
rats).
Fig. 1 Time course changes of cerebral concentrations of Glu (A), Gln (B), Glu + Gln (C) and Glu/Gln ratio (D) determined by HPLC in deproteinized
tissue extracts of rats receiving mTBI or sTBI. Controls are represented by a group of sham operated rats (n = 6). Values at each time-point are the
mean of six animals (3 left + 3 right hemispheres). Standard deviations are represented by vertical bars. Tissue preparation, sample processing,
pre-column derivatization with OPA, and HPLC conditions for the separation of OPA-amino acid adducts are fully described under Materials and
Methods. *Significantly different from controls, P < 0.01. **Significantly different from corresponding time of mTBI rats, P < 0.05.
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Discussion
In view of their multiple and complex biochemical roles, FAA and
ACCG are of crucial importance for maintaining brain tissue meta-
bolic homeostasis [6, 7]. For this reason, several studies have
been carried out in both acute and chronic cerebral pathologies, in
the majority of cases focussing on changes occurring to amino
acidic neurotransmitters [4, 11]. TBI studies have also mainly
focused on amino acids involved in neurotransmission [33], espe-
cially with regard to changes in their extracellular concentrations
[32, 43].
Results reported in the present study provide a comprehensive
picture of the effects of two levels of TBI, characterized by diffuse
axonal injury, on the cerebral concentrations of 18 standard FAA and
6 ACCG (including two amino acids of the urea cycle), and of the main
neuron specific N-acetylated amino acid (NAA). A general remark is
that, once again, mTBI modestly and transiently affects the concen-
trations of FAA and ACCG, as well as of NAA and it is clearly distin-
guishable from sTBI causing a profound, long-lasting imbalance in
the homeostasis of the aforementioned substances.
Data referring to Glu and Gln levels indicate that mTBI did not
cause significant excitotoxic conditions, possibly maintaining
Fig. 2 Time course changes of cerebral
concentrations of NAA (A), Asp (B), and
NAA + Asp (C) determined by HPLC in
deproteinized tissue extracts of rats
receiving mTBI or sTBI. Controls are rep-
resented by a group of sham operated
rats (n = 6). Values at each time-point are
the mean of six animals (3 left + 3 right
hemispheres). Standard deviations are
represented by vertical bars. Tissue prepa-
ration, sample processing, pre-column
derivatization with OPA, and HPLC condi-
tions for the separation of NAA and of
OPA-amino acid adducts are fully
described under Materials and Methods.
*Significantly different from controls,
P < 0.01. **Significantly different from
corresponding time of mTBI rats,
P < 0.01.
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unaltered the Glu-Gln cycle between neurons and astrocytes [11].
Conversely, sTBI induced a net increase in both Glu and Gln through-
out the observational period (120 hrs), with high concentrations of
Glu any time post-impact. This indicates that with this level of injury
Glu excitotoxicity might be caused by a combined increase in extra-
cellular Glu [32, 43, 44] and in its total cerebral concentration. More-
over, the increase in the Glu/Gln ratio following sTBI should indicate
an impairment in the neuron-astrocyte Glu-Gln cycle which should
contribute to a decreased rate in Glu removal from the extracellular
milieu and consequent exacerbation of the cytotoxic effects of excess
Glu outside cells [11, 33].
It can be hypothesized that the Glu increase is related to NAA
changes. As previously observed, alterations in NAA homeostasis are
transient after mTBI and permanent after sTBI [45]. These are caused
by biochemical and molecular changes occurring to mitochondrial
functions, as well as to the expression of the genes encoding for the
enzymes catalysing NAA biosynthesis and degradation [35]. In the
present study, we could show that only after sTBI the decrease in
NAA is not stoichiometrically accompanied by an in increase in Asp
(Fig. 2). By subtracting the pre-impact NAA concentration, it is possi-
ble to calculate that 2.87, 4.12, 4.29 and 4.56 lmol/g wet weight of
NAA are hydrolysed at 6, 24, 48 and 120 hrs post-sTBI, respectively.
Fig. 3 Time course changes of cerebral
concentrations of GABA (A), and Tau (B)
determined by HPLC in deproteinized tis-
sue extracts of rats receiving mTBI or
sTBI. Controls are represented by a group
of sham operated rats (n = 6). Values at
each time-point are the mean of six ani-
mals (3 left + 3 right hemispheres). Stan-
dard deviations are represented by vertical
bars. Tissue preparation, sample process-
ing, pre-column derivatization with OPA,
and HPLC conditions for the separation of
OPA-amino acid adducts are fully
described under Materials and Methods.
*significantly different from controls,
P < 0.01. **significantly different from
corresponding time of mTBI rats,
P < 0.01.
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At the same time-points increase in Asp is equal to 1.64, 2.57, 2.80
and 2.88 lmol/g wet weight, i.e. when taking into account Asp deriv-
ing from NAA hydrolysis deficits of 1.23, 1.55, 1.49 and 1.68 lmol/g
wet weight of Asp are observed in the brain tissue of severely injured
rats. It is highly probable that these amounts of Asp are rapidly con-
verted into Glu via the activity of Asp aminotransferase, through the
reaction Asp + a-ketoglutarate ↔ Glu + oxaloacetate [11], thereby
potentially linking degradation of NAA with Glu and its excitotoxic
effects. As this phenomenon is confined to sTBI only, it can be postu-
laed that, under pathological conditions causing imbalance of NAA
homeostasis with a net decrease in its cerebral concentration below a
given threshold value (lower than the lowest value recorded in mTBI
rats), an increase in Asp can trigger its transamination into Glu by
aminotransferase, significantly concurring to cause an increase in Glu
concentrations. To corroborate this hypothesis, it should be under-
lined that significantly lower values of Glu are present in the brain of
rats affected by experimental Canavan disease [46, 47], the rare
inborn error of metabolism caused by defects in the enzyme (N-acety-
laspartoacylase) degrading NAA into Asp and acetate [48]. Under
these pathological conditions, NAA is not hydrolysed by oligodendro-
cytes thus decreasing brain Asp availability, in turn producing about
50% lower Glu value [46, 47]. That is, brain Glu metabolism is, at in
lest in part, linked to the turnover rate of NAA. Therefore, control of
NAA homeostasis at the enzymatic level might be a new, highly rele-
vant target for new pharmacological approach aimed at reducing Glu
excitotoxicity.
We found that GABA had transient increase at early stages post-
mTBI, and underwent significant increase in sTBI even at relatively
long times after impact (24, 48, and 120 hrs), substantiating results
of a very recent study obtained in a mouse model of mTBI [49]. Since
GABA is the only antagonist of Glu, it is conceivable that such an
increase is aimed at counteracting the excitotoxic effect of increased
Glu. However, if we take into account the Glu/GABA ratio, 7.65 is the
value found in controls. Rats after mTBI exhibit a Glu/GABA ratio of
6.65, 5.67, 7.11, and 7.69 at 6, 24, 48 and 120 hrs post-injury,
respectively, whilst at the same time-points sTBI animals have Glu/
GABA ratios of 7.16, 7.29, 7.57, and 8.59. That is, the increase in
GABA after sTBI was not sufficient to counteract excitotocity caused
by the increase in Glu.
It is presumable that Glu decarboxylation, catalysed by Glu
decarboxylase, would have the dual effect of decreasing total Glu
concentration and simultaneously increasing GABA concentration. In
light of this, it should be borne in mind that GABA is also part of a
cycle between two cellular compartments: GABAergic neurons
Fig. 4 Time course changes of cerebral concentrations of Ser (A), Thr (B), Gly (C) and Ala (D) determined by HPLC in deproteinized tissue extracts
of rats receiving mTBI or sTBI. Controls are represented by a group of sham operated rats (n = 6). Values at each time-point are the mean of six
animals (3 left + 3 right hemispheres). Standard deviations are represented by vertical bars. Tissue preparation, sample processing, pre-column
derivatization with OPA, and HPLC conditions for the separation of OPA-amino acid adducts are fully described under Materials and Methods. *Sig-
nificantly different from controls, P < 0.05. **Significantly different from corresponding time of mTBI rats, P < 0.01.
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producing GABA from Glu and then releasing GABA to modulate
excitatory effects of Glu, and astrocytes re-uptaking GABA, deami-
nating and inserting it into the TCA cycle to indirectly generate first
Glu and finally Gln which is again taken up by neurons, thereby
closing the complex Glu-Gln/GABA cycle occurring between neurons
and astrocytes [11, 33]. It has previously been demonstrated that
the loss of one carbon unit occurring in neurons upon GABA forma-
tion, is restored in astrocytes using acetate as the preferential car-
bon donor substrate [11, 50]. Again, it is therefore highly possible
that acetate deriving from increased NAA hydrolysis, as it occurs in
sTBI, may be used to support the increased rate of the Glu-Gln/
GABA cycle.
It is also possible that the increase in Tau in sTBI injured animals
is correlated with the decrease in NAA and the concomitant decrease
in osmolarity. It has been indicated that both compounds, besides var-
ious still debated biological functions [51–55], play a determining con-
tribution in controlling cerebral osmolarity [52, 55, 56]. Even though
some studies showed a decrease in Tau after TBI [57–59], our results
are in line with those reported by others [60, 61] and are logically con-
nected to dysfunctional NAA homeostasis following sTBI and to a pre-
cise role of osmolite regulator performed by cerebral Tau. It is also
possible that the increase in Tau is finalized to counteract Glu excito-
toxic effects since it has been reported that Tau can directly interact
with the NMDA receptor subtype decreasing the binding of Glu [62].
Fig. 5 Time course changes of cerebral
concentrations of Arg (A), Citr (B), and
Arg/Citr ratio (C) determined by HPLC in
deproteinized tissue extracts of rats
receiving mTBI or sTBI. Controls are rep-
resented by a group of sham operated
rats (n = 6). Values at each time-point are
the mean of six animals (3 left + 3 right
hemispheres). Standard deviations are
represented by vertical bars. Tissue prepa-
ration, sample processing, pre-column
derivatization with OPA, and HPLC condi-
tions for the separation of OPA-amino
acid adducts are fully described under
Materials and Methods. *Significantly dif-
ferent from controls, P < 0.01. **Signifi-
cantly different from corresponding time
of mTBI rats, P < 0.01.
8 ª 2016 The Authors.
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The tendency to modest, transient increase in excitatory amino
acids in mTBI and to marked, protracted increase following sTBI is
also clearly indicated by the changes in the brain values of free Ser
and Gly, both interacting with the NMDA Glu receptors and actively
contributing to the excitatory effects of Glu [63]. Although we did not
separate L-Ser from D-Ser (the stereoisomer actively binding to the
NMDA receptors), it is presumable that the 1.3-1.5 times increase in
total Ser observed in sTBI rats generates an increase in the two iso-
mers at least equal to the relative ratio recorded under physiological
conditions, when D-Ser has been reported to be about the 15% of the
total Ser pool in adult rats [64]. If this is correct and since the only
source of cerebral D-Ser is the racemization of L-Ser via the D-Ser
racemase enzyme, a sufficient increase in the D-Ser levels might have
been formed after sTBI and contributed to Glu excitotoxicity. The con-
siderable increase in Gly recorded during the first 48 hrs post-sTBI
completes the picture of a general exacerbation of excitatory phenom-
ena, mediated by the increase in the aforementioned free amino acids
that have been observed using different types of measures in various
models of TBI [65–67].
In our experiments, we also found that sTBI, but not mTBI, causes
significant changes in Arg and Citr concentration, and in the Arg/Citr
ratio. This latter is an indirect indicator of the activity of NO synthases
[68] and its decrease is generally attributed to the activation of iNOS,
i.e. the inducible NOS isoenzyme responsible for cellular nitrosative
stress [69]. It is worth recalling that in previous experiments we
found increased nitrosative stress following sTBI as evaluated by
measuring the brain tissue concentration of nitrite and nitrate, the
stable end-products of NO metabolism [70].
The last remarkable finding of this study concerns a significant
alteration of the concentrations of the amino acids and amino group
containing compound involved in the so called methyl-cycle, namely
Met, SAH and L-Cystat. Again, these changes were recorded only in
brain tissue of animals experiencing a severe level of TBI (Table 1).
Concomitant decrease in Met, and increase in SAH and L-Cystatt
strongly suggest either reduced availability of the main methyl-group
donor S-adenosylmethionine (SAM) or a decreased rate in the forma-
tion of free cysteine (Cys) originating from the hydrolysis of L-Cystat
catalysed by cystathionine c-lyase. Alterations of SAM homeostasis
have been proven to be involved in several neurodegenerative
pathologies, including Alzheimer’s disease [71] and multiple sclerosis
[72]. On the other hand, a Cys decrease may negatively influence the
rate of GSH biosynthesis, thereby contributing to the previously
observed decrease in GSH content as a consequence of marked
oxidative stress occurring after sTBI [34]. It was recently reported
that groups of mTBI and sTBI patients had decreased levels of circu-
lating Met and SAM, much more evident in sTBI than in mTBI
patients, thus confirming the existence of an altered methyl-cycle
after a traumatic insult [73].
According to the timing of the changes in FAA, ACCG and NAA it
is possible to evidence substantial differences between the two
levels of injury. When considering mTBI, most of the changes in
FAA, ACCG and NAA occurred at early-phases post-injury (6–24 hrs)
and may therefore be attributed to the traumatic event and to the
immediate onset of the neurometabolic cascade affecting various
biochemical pathways [28, 67], At longer times post-impact, animals
experiencing mTBI showed normalization of the various compounds
measured, indicating that reparative processes were mainly acting in
the mildly injured brain after 48–120 hrs from trauma, as already
found in previous studies using the same experimental model [27,
38, 45, 70]. Concerning sTBI, it is possible to assume that the
changes in FAA, ACCG and NAA occurring at early-phases post-
injury (6–24 hrs) were also in this case related to the traumatic
event and to the triggering of the neurometabolic cascade affecting
various biochemical pathways [28, 67]. At longer times post-impact,
rats receiving sTBI showed a further deterioration in the values of
FAA, ACCG and NAA, very probably because of secondary mecha-
nisms and reactions (inflammatory processes, oxidative/nitrosative
stress, persistent mitochondrial malfunctioning) involving injured
still viable cerebral tissue.
It is worth recalling that the results reported in the present study
have been obtained using deproteinized brain samples (saved at
80°C) from three cohorts of rats (controls, mTBI and sTBI) in
which, with the same methodology to induce TBI, we have previously
shown that complex metabolic, enzymatic and gene mechanisms are
responsible for profound changes in NAA homeostasis [35], sus-
tained oxidative stress with neuroglobin overexpression and GSH
depletion [34] and glucose dysmetabolism with energy metabolism
imbalance [36]. In these studies, differential injury severity caused
transient (in mTBI rats) or irreversible changes in (in sTBI rats). By
combining these previous data with those here shown and referring
to FAA and ACCG, it is possible to conceptualize an even more
detailed picture of the plethora of biochemical functions (and of their
interrelationships) undergoing changes, the duration and severity of
which only depend on the severity of injury.
In conclusion, although these results are not immediately translat-
able into the clinical setting particularly because of the differences
between ‘rat time’ and ‘human time’, this study offers a panorama of
the influence of different levels of TBI on the time course of changes
of FAA and ACCG, highlighting previously unknown connections
between alterations in NAA homeostasis and changes of amino acids
directly or indirectly linked to post-injury excitotoxic phenomena.
These and other modifications (dysfunction of the methyl-cycle,
increased nitrosative stress) are clearly reversible and of limited mag-
nitude in mTBI, thus corroborating the existence, and the rather com-
plex biochemical basis, of a window of metabolic brain vulnerability
after mTBI involving main cell biological functions [45, 67, 70]. Given
the number of the ‘disturbed’ biochemical tasks during this period of
time, it is possible that repeat mTBIs may cause chronic impairment
of these systems up to a point of permanent damages of key cellular
bio-molecular ‘apparatuses’. This might potentially be involved in the
development of chronic post-traumatic encephalopathy observed, for
instance, in athletes with a long history of multiple concussions [74].
Ultimately, we have again demonstrated that mTBI and sTBI have two
clearly distinct patterns of molecular evolution, not in linear, propor-
tional relationship. The force acting on the brain tissue at the time of
the impact is the main determinant of the reactions ignited and, ulti-
mately, of the fate of cerebral tissue. This should carefully be borne in
mind when deciding the treatment of an mTBI or an sTBI patient and
when developing new pharmacological interventions that could not be
effective in all TBIs.
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